SAN FRANCISCO (AP) _ Twist Bioscience Corp. (TWST) on Thursday reported a loss of $22.6 million in its fiscal first quarter.
The San Francisco-based company said it had a loss of $1.18 per share.
The maker of synthetic DNA for the biotechnology industry posted revenue of $11.5 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $9.7 million.
Twist Bioscience expects full-year revenue in the range of $47 million to $49 million.
Twist Bioscience shares have declined almost 7 percent since the beginning of the year.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TWST at https://www.zacks.com/ap/TWST